An epitope vaccine derived by analyzing clinical trial samples safeguards hosts with prior exposure to S. aureus against reinfection

Journal:

Science Translational Medicine

Published:

2025-08-20

DOI:

10.1126/scitranslmed.adr7464

Affiliations:

7

Authors:

27

Go to article

Institutions	Authors	Share
Army Medical University, China	17.000000 17.000000	0.63
Institute of Microbiology (IM), CAS, China	3.000000	0.11
Beijing Jishuitan Hospital, China	3.000000	0.11
Chengdu Olymvax Biotechnology Co. Ltd., China	3.000000	0.11
General Hospital of Tibet Military Area Command of PLA, China	0.500000	0.02
State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, China	0.500000	0.02

Interested in Clinical Sciences?